Synthace Named a 2022 UK’s Best Workplaces™ for Women
Biology could be one of the most powerful technologies available to help arrest the devastation of climate change - so what's stopping us?
UCL Selects Synthace to Help Make Digital, Cloud-Based Lab Work a Reality
Building a lab of the future? You're not alone. UCL selects Synthace to help them bridge the gap between digital and physical spaces.
IDBS and Synthace Announce Strategic Partnership to Streamline Bioprocess Data Management
Synthace and IDBS have entered a strategic partnership to provide state-of-the-art data foundations for experimentation in HTPD
Synthace Raises $35M to Expand Access to Its Revolutionary R&D Technology for Life Changing Research
Horizons Ventures and Sofinnova Partners Co-Lead Investment in Market-leading Life Sciences Software Company That Transforms the Way Scientists Autom
Synthace Unveils First Life Sciences R&D Cloud Addressing Complexity, Speed & Reproducibility for Scientists
First ever no-code platform lowers barriers to automated biological experimentation and insight sharing.
Veteran Technology Executive Joins Synthace to Accelerate Its Mission to Revolutionize the Life Science Research Market
Synthace hires Guy Levy-Yurista as Chief Executive Officer.
Synthace More than Doubles Its Annual Recurring Revenue; Expands Customer Footprint with the Top Pharma Companies in 2020
Strong financial performance and achievement of other key milestones demonstrate the growing strength of Synthace’s offering within biopharma/biotech.
Synthace Appoints Dr. Nick Jurascheck as VP of Engineering
Dr. Jurascheck brings with him more than twenty years of experience spanning senior technology roles in high-tech product companies and consultancies.
Synthace and Ipsen Partner to Accelerate Novel Therapeutic Development through Automation
Two European leaders in biopharma and integrative software are working together to advance drug discovery.